Kumar Anup, Gupta Narmada P, Hemal Ashok K, Wadhwa Pankaj
Department of Urology, All India Institute of Medical Sciences, Ansari Nagar,New Delhi, India.
J Endourol. 2007 Jun;21(6):578-82. doi: 10.1089/end.2006.0359.
To compare the efficacy and adverse effects of oral diclofenac, topical eutectic mixture of local anesthesia (EMLA), and their combination for pain control during shockwave lithotripsy (SWL) and to investigate the need for supplemental analgesia, patient satisfaction, and overall treatment outcomes.
A series of 240 consecutive patients with urolithiasis scheduled for SWL between May 2006 and December 2006 were randomized equally into three groups that were treated as follows: group A oral (tablet) diclofenac sodium 60 minutes prior to SWL (50 mg for body weight <70 kg; 100 mg for body weight >70 kg); group B occlusive dressing of EMLA (5 g) 60 minutes prior to SWL; group C combination of oral diclofenac sodium (in the prescribed dose) and occlusive dressing of EMLA (5 g) 60 minutes prior to SWL. A visual analog scale (VAS) was used for the subjective evaluation of pain. The various parameters were recorded and analyzed statistically.
The total number of shock waves delivered, the maximum voltage used, and SWL duration were statistically greater in group C (P < 0.0001). The VAS scores at 15, 30, 45, 60, and 120 minutes and the supplemental analgesia requirement were statistically less in group C (P < 0.0001). The stone fragmentation rate, stone-free rate at 3 months (88.75%), and modified Efficiency Quotient (0.64) were statistically greater in group C (P < 0.0001). The post-SWL auxiliary procedure rate (P < 0.0001) and Steinstrasse rate (P = 0.03) were statistically less in group C.
The use of a combination of oral diclofenac sodium and an occlusive dressing of EMLA cream during SWL provides adequate analgesia with minimal morbidity, avoids the need for parenteral analgesics and their attendant side effects, and improves the success rate of SWL.
比较口服双氯芬酸、外用复方利多卡因乳膏(EMLA)及其联合应用在冲击波碎石术(SWL)期间控制疼痛的疗效和不良反应,并调查补充镇痛的必要性、患者满意度及总体治疗结果。
2006年5月至2006年12月期间,连续入选240例计划接受SWL的尿石症患者,将其平均随机分为三组,治疗方法如下:A组在SWL前60分钟口服(片剂)双氯芬酸钠(体重<70 kg者50 mg;体重>70 kg者100 mg);B组在SWL前60分钟用EMLA(5 g)进行封闭敷贴;C组在SWL前60分钟联合口服双氯芬酸钠(按规定剂量)和用EMLA(5 g)进行封闭敷贴。采用视觉模拟评分法(VAS)对疼痛进行主观评估。记录各项参数并进行统计学分析。
C组的总冲击波发射次数、使用的最大电压和SWL持续时间在统计学上更高(P<0.0001)。C组在15、30、45、60和120分钟时的VAS评分及补充镇痛需求在统计学上更低(P<0.0001)。C组的结石破碎率、3个月时的无石率(88.75%)和改良效率商数(0.64)在统计学上更高(P<0.0001)。C组SWL后的辅助程序率(P<0.0001)和石街发生率(P=0.03)在统计学上更低。
在SWL期间联合使用口服双氯芬酸钠和EMLA乳膏封闭敷贴可提供充分镇痛,且发病率最低,避免了使用胃肠外镇痛药及其伴随的副作用,并提高了SWL的成功率。